Net worth tracking
Login Sign Up
Become a Premium Member
  • All Opinions
  • Top Picks
  • Experts
  • Companies
  • Discover
Watch List
Home » Stock Lists

BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks

Allan Tong Posted On August 25, 2020
0
0
Shares
  • Share On Facebook
  • Tweet It

healthcare stock

The U.S. companies that supply medical equipment (medical equipment stocks), from test tubes to surgical robotics. That’s the Stryker Stock (SYK-N), Boston Scientific (BSX-N), Becton, Dickinson (BDX-N) and Intuitive Surgical (ISRG-Q). Took a hit from the COVID-19 lockdown, so are they now bouncing back?

A friend is weighing the risks and rewards of permitting his elderly mother to consult her doctor at a hospital to schedule non-essential surgery. That got me thinking about the backlog of elective surgeries across North America and those medial equipment stocks. Are they worth investing in?

Top 4 Medical Equipment Stocks

Let’s have a look at what we see as the Top 4 North American Medical Equipment Stocks starting with the BDX Stock up to the Stryker Stock.

The BDX Stock: Becton, Dickinson

The BDX Stock: Becton, Dickinson (BDX-N)

A giant medical equipment stock, BDX supplies the world’s hospitals with syringes and other products. Before COVID hit our shores in early February, the company reduced its forward earnings after missing them; the stock then got punished.

However, the pandemic helped BDX, since most of its products are disposable. Then again, during the spring lockdown, surgeries were cancelled across the board, so use of BDX’s products nearly halted. Its chart this year has been rocky, though earlier this month, the stock returned to previous highs above $280 while it has met or narrowly beat its EPS in the past four quarters. BDX continues to be profitable at a margin of 7.13% and a 15.41% five-year average revenue growth. Forward PE stands at 20.44x and it pays a dividend of 1.2%.

A lot rides on how America handles COVID in the coming months for the number of surgeries to increase or fall (if there are regional lockdowns). Nobody can tell the future of the States, but 62% of Americans want Trump to do more to fight the outbreak, while the number of Americans who know someone diagnosed from COVID has leapt from 40% in early June to an alarming 67% in mid August. It’s possible that BDX can return to those $280 highs which are also the price target. Analyst Barry Schwartz continues to hold it.

The BSX Stock : Boston Scientific

The BSX Stock: Boston Scientific (BSX-N)

Another American supplier of surgical devices, including heart operations. Though it’s been gently rising ever since the late-March bottom, BSX hasn’t yet returned to its pre-pandemic levels. Jamie Murray feels that the sell-off was overdone and expects its rise to continue.

It trades at a 32x PE, but pays no dividend. Despite the spring lockdown, BSX offers revenue growth YOY of 9.28% though the one-year total return is -5.42%. It beat EPS in three of its last four earnings periods, and the market expects its EPS to leap from 8 cents in Q2 to 24 cents in Q3 (to reported on Oct. 21).

If it does, then expect BSX stock to return to previous highs at a price target over $45. The stock continues to flirt with $40. Murray made this a top pick a month ago, banking on the number of elective surgeries continuing to rise.

Top #3 Stocks: Medical supply stocks Intuitive Surgical

The ISRG Stock: Intuitive Surgical (ISRG-Q)

We’ve all heard of A.I. and the future of cars, but what about robots in surgery? We’re not talking about actual robots performing on humans, but rather high-tech instruments that help surgeons see, cut and stitch more accurately.

Both Jamie Murray and Bruce Murray (unrelated) see strong long-term growth ahead for the company as more surgeons adapt robotic devices. ISRG‘s market share is currently only 4%, but Bruce Murray expects the company to grow 50% next year and 20% after that. However, investors have already caught onto this stock and ISRG stock has almost doubled from the March 23 bottom; it has passed its $655 price target and is flirting with $700.

Also, it trades at a high 73x PE and doesn’t pay a dividend. There’s little to doubt the growth projections of the Murrays, but its share run-up makes this a candidate to buy on a pullback, even a modest one, then hold on for 20 years, as Jamie Murray suggests. Of all the stocks examined here, Intuitive has performed the best this year so far.

Top #4 Stocks: Medical supply stocks Stryker

The Stryker Stock: Stryker (SYK-N)

Stryker enjoyed a bounce after beating Q2 revenues and earnings a month ago, but has been rangebound between $180 and $205 since Easter. Typical of the other medical device stocks here, it has yet to return to pre-COVID highs of $226, but trades at a 27.44x PE, far more reasonable than peers including Intuitive Surgical.

The Stryker Stock has also beaten its last four quarters. Paul Harris made it a top pick recently, encouraged by the loyalty that surgeons devote to this brand and the demographic play, since Stryker specializes in hip, knee and shoulder surgery. Barry Schwartz scores it high for deploying cash effectively and making accretive acquisitions.

It bought Wright Medical late last year, a company specializing in shoulders, feet and ankles. Like the other names here, the Stryker Stock will benefit from the continued return of elective surgeries in the U.S. It pays you a 1.22% dividend as you wait.

0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
Melisa R. H. July 1, 2022
3 gems from the Collision technology conference
Allan Tong June 29, 2022
TSX rises on bank earnings, Wall St. on momentum
Read Next

TSX rises on bank earnings, Wall St. on momentum

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Top Reviews

    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
    • The Ugly Truth About Identity Theft – Free Credit Report
      7
  • Popular Posts

    • FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
    • 3 gems from the Collision technology conference
    • Intertape Polymer Group and More at 52-week Highs & Lows (Jun 22-28)
    • 3 defensive stocks to find stability with your money
    • Markets slide on recession fears
  • Stock Lists

    • 3 defensive stocks to find stability with your money
      June 21, 2022
    • 3 rock stars of the mineral stocks
      June 15, 2022
    • 3 stocks to profit from revenge travel
      June 7, 2022
    • Are tech stocks alive?
      May 31, 2022
    • 3 dividend stocks to fight inflation
      May 24, 2022


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search